S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
PRI   120.64 (+1.31%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
Log in

OTCMKTS:PURE - Pure Bioscience Stock Price, Forecast & News

$0.37
+0.01 (+2.82 %)
(As of 01/28/2020 04:00 PM ET)
Today's Range
$0.37
Now: $0.37
$0.41
50-Day Range
$0.27
MA: $0.30
$0.38
52-Week Range
$0.20
Now: $0.37
$0.52
Volume43,025 shs
Average Volume45,350 shs
Market Capitalization$29.20 million
P/E RatioN/A
Dividend YieldN/A
Beta0.1
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. Read More…

Industry, Sector and Symbol

Industry Miscellaneous chemical products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PURE
CUSIPN/A
Phone619-596-8600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.91 million
Book Value$0.02 per share

Profitability

Net Income$-6,550,000.00
Net Margins-297.79%

Miscellaneous

Employees9
Market Cap$29.20 million
Next Earnings Date3/4/2020 (Estimated)
OptionableNot Optionable

Receive PURE News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE and its competitors with MarketBeat's FREE daily newsletter.


Pure Bioscience (OTCMKTS:PURE) Frequently Asked Questions

What is Pure Bioscience's stock symbol?

Pure Bioscience trades on the OTCMKTS under the ticker symbol "PURE."

How were Pure Bioscience's earnings last quarter?

Pure Bioscience, Inc. (OTCMKTS:PURE) announced its earnings results on Friday, December, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.40 million for the quarter. Pure Bioscience had a negative net margin of 297.79% and a negative return on equity of 422.56%. View Pure Bioscience's Earnings History.

When is Pure Bioscience's next earnings date?

Pure Bioscience is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Pure Bioscience.

Has Pure Bioscience been receiving favorable news coverage?

Media stories about PURE stock have been trending somewhat negative this week, according to InfoTrie. The research group rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pure Bioscience earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Pure Bioscience.

Who are some of Pure Bioscience's key competitors?

Some companies that are related to Pure Bioscience include Flotek Industries (FTK), HighCom Global Security (HCGS), Artemis Therapeutics (ATMS), Ener-Core (ENCR) and GlyEco (GLYE).

What other stocks do shareholders of Pure Bioscience own?

Who are Pure Bioscience's key executives?

Pure Bioscience's management team includes the folowing people:
  • Mr. Henry R. Lambert, CEO, Sec. & Director (Age 68)
  • Mr. Mark Stuart Elliott, VP of Fin. (Age 44)
  • Mr. Thomas Richard Myers, Chief Operating Officer (Age 67)
  • Ms. Bridget C. Tinsley-Cormier M.S., Sr. VP of Technology & Bus. Devel. and VP of Market Devel.

How do I buy shares of Pure Bioscience?

Shares of PURE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pure Bioscience's stock price today?

One share of PURE stock can currently be purchased for approximately $0.37.

How big of a company is Pure Bioscience?

Pure Bioscience has a market capitalization of $29.20 million and generates $1.91 million in revenue each year. Pure Bioscience employs 9 workers across the globe.View Additional Information About Pure Bioscience.

What is Pure Bioscience's official website?

The official website for Pure Bioscience is http://www.purebio.com/.

How can I contact Pure Bioscience?

Pure Bioscience's mailing address is 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA, 91730. The company can be reached via phone at 619-596-8600 or via email at [email protected]bibimac.com.


MarketBeat Community Rating for Pure Bioscience (OTCMKTS PURE)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  88 (Vote Underperform)
Total Votes:  180
MarketBeat's community ratings are surveys of what our community members think about Pure Bioscience and other stocks. Vote "Outperform" if you believe PURE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PURE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Featured Article: What is a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel